The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: venlafaxine hcl     Quarter: 2016Q3

Total Drug/Injury Combinations: 292     Number of Pages: 15

DRUGNAME PT EventCount
VENLAFAXINE HCL Electrocardiogram QT prolonged 2 view events
VENLAFAXINE HCL Emotional disorder 2 view events
VENLAFAXINE HCL Faeces discoloured 2 view events
VENLAFAXINE HCL Feeling jittery 2 view events
VENLAFAXINE HCL Gastrointestinal motility disorder 2 view events
VENLAFAXINE HCL Haemorrhage 2 view events
VENLAFAXINE HCL Heart rate decreased 2 view events
VENLAFAXINE HCL Hypotension 2 view events
VENLAFAXINE HCL Irritability 2 view events
VENLAFAXINE HCL Leukoencephalopathy 2 view events
VENLAFAXINE HCL Listless 2 view events
VENLAFAXINE HCL Mania 2 view events
VENLAFAXINE HCL Mood altered 2 view events
VENLAFAXINE HCL Muscle tightness 2 view events
VENLAFAXINE HCL Myoclonus 2 view events
VENLAFAXINE HCL Off label use 2 view events
VENLAFAXINE HCL Pallor 2 view events
VENLAFAXINE HCL Peripheral swelling 2 view events
VENLAFAXINE HCL Prescribed overdose 2 view events
VENLAFAXINE HCL Rhabdomyolysis 2 view events

Total Drug/Injury Combinations: 292     Number of Pages: 15

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)